Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone for Symmetric Lipomatosis associated with Neuropathy
NCT04821583Phase 3Unknown
- Sponsor
- Erasmus MC
- Start
- Jun 2021
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocortisone in multiple symmetric lipomatosis (MSL), sponsored by Erasmus MC. Status: unknown.
02
Drugs
hydrocortisone
03
Conditions
multiple symmetric lipomatosis (MSL)
Beyond the preview
Go deeper on NCT04821583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04821583.